Don't you feel the love and concern for patients(-: Johnson & Johnson no doubt with this forecast...they are the ones behind the scenes in Zytiga/Abiraterone (it is made in Canada, probably cheaper for them). I can see the logic from J&J, they just got FDA approval for 'Abby' and these little pills will cost us $5,000 a month for (pills???). I did some investigation, as I know these firms are only trying to service us (I mean serve us patients). Well 'Abby' targets the exact same enzyme that Ketoconazole does (namely CYP17)...and I kind of believe it is re-engineered Keto with a new patent, perhaps it is more potent, the price surely is more potent...Keto from Canada pharmas from as low as $130 for 90 pills vs. $5,000 for 120 of the 'Abby' (approx.).
The clues on this: in trials Abby patients whom did Keto prior were excluded (mentioned by DR. Myers to, in a video), they target the same enzyme, they both require you to use Prednisone and they have similar side effects to some degree. The big one is Dr. Swayers whom invented MDV3100, in a blog interview thing mentioned they both target the enzyme CYP17.
Now since many companies are seeing they can cash in on cancer patients more easily than ever, our new drugs are likely to be based upon what level of pain and extraction they can get away with. Examples of our rip offs: Provenge $93,000 and is not a cure, Revlimid pills around $150 each, Leukine injections patients cost would be around $5,000-7000 a month. So, based upon these findings....the mole-mar drug analogy theory is: most newer protocols for drugs and vaccines have set the bar at around $5,000 a month as acceptable and is fine for
open season on us customers and bigger profits for the humanity lovers. Maybe for those without insurance they may throw a few bones out of this high priced items, to look wonderful to the public. (great....celebrate).
I suspect MDV3100 and ANR-509 to get approved in 1-2 years, let us see what that price tag is in comparison and just for kicks!!! I think they are smart enough to make it lower and grab market share, but just guessing. I have to fly back to Lybia today (LOL).
Funny how the low priced stuff is not used by hardly any doctors, must be a coincidence.
Casodex+proscar found to be about equal to Lupron+casodex in controlling non refractive PCa....how many are getting anything other than Lupron???? Beuhler....Beuhler??
Post Edited (mole-mar-gaddafy) : 6/2/2011 10:46:11 AM (GMT-6)